FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine, namely to anti-tuberculosis composition. Claimed is pharmaceutical composition which includes sodium salt of para-aminosalicylic acid, zinc sulfate, sorbitol, polyvinylpyrrolodone, citric acid, stearic acid salt, sodium carboxymethyl starch, colloidal silicon dioxide and polyethylene glycol in amounts stated in invention formula.
EFFECT: pharmaceutical composition is characterised by high therapeutic activity, satisfactory technological characteristics and has storage term more than 2 years.
8 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
PHARMACEUTICAL COMPOSITION WITH ANTI-TUBERSULOSIS ACTION | 2009 |
|
RU2420288C1 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
MEDICINE FOR TREATING TUBERCULOSIS | 2009 |
|
RU2487702C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
Authors
Dates
2011-07-27—Published
2009-08-07—Filed